Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The Summary of Product Characteristics (SmPC) clearly states that it is unknown whether semaglutide is excreted in human breast milk, and due to this uncertainty, the medication should be avoided during lactation
Here is a brief guide
What Remains Essential With or Without Medication Thorough medical evaluation and ongoing clinician supervision Sustainable diet and physical activity changes Patience with realistic timelines, as trials evaluated outcomes over 64 weeks or longer Awareness of potential risks and side effects Individual results vary widely based on adherence, lifestyle factors, medical history, and biological response
These response rates explain the explosive interest in tirzepatide as a weight loss intervention and why it consistently appears in discussions about the best peptide stacks for weight loss
